Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-31

Clinical Trial Update: Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial assessing nabilone for attenuation of anorexia and improvements in nutritional status and quality of life in patients with non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cesamet (Nabilone) (Nabilone)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Non-Small Cell Lung Cancer, Anorexia | Phase 2, Phase 3 | Status: UNKNOWN